Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site

Click on country-registry for comparison

Flag	Country Registry	Registration period	No. of cases included	Complete FU		Incomplete FU: loss to FU						% with Complete FU at 5 years	Median FU (in months)
				Alive/dead	At end of FU	No.	%	% lost to FU: years from diagnosis
				No.	%	No.	%	<1	1-3	3-5	>5
	China - Shangai	1992-1995	868	841	96.9	27	3.1	0.3	1.1	1.2	0.5	97.4	77.9
	India - Karunagappally	1991-1997	74	73	98.6	1	1.4	1.4	0.0	0.0	0.0	98.6	57.0
	Thailand - Chiang Mai	1993-1997	130	82	63.1	48	36.9	7.7	11.5	10.8	6.9	70.0	37.5
	Thailand - Lampang	1990-2000	133	133	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	59.3
	Thailand - Songkhla	1990-1999	333	213	64.0	120	36.0	7.5	9.3	7.8	11.4	75.4	71.0
	Uganda - Kampala	1993-1997	39	22	56.4	17	43.6	25.6	15.4	0.0	2.6	59.0	7.5

Other tables available:

- Table 1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b:	Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6:	Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9:	Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period